Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Intersect Ent Inc (XENT)

Intersect Ent Inc (XENT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource Utilization Business Wire - Tue Jan 25, 2022

Intersect ENT ® , Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced positive results of an observational,...

XENT : 28.24 (unch)
Orthofix Announces Appointment of Thomas A. West to Board of Directors Business Wire - Tue Dec 14, 2021

Orthofix Medical Inc . (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that Thomas A. West has been named to the Company’s Board of Directors and appointed...

OFIX : 18.68 (-1.01%)
XENT : 28.24 (unch)
Intersect ENT: Q3 Earnings Snapshot AP - Tue Nov 2, 2021

MENLO PARK, Calif. (AP) _ Intersect ENT Inc. (XENT) on Tuesday reported a loss of $31.8 million in its third quarter.

XENT : 28.24 (unch)
Intersect ENT Reports Third Quarter 2021 Financial Results Business Wire - Tue Nov 2, 2021

Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today reported financial results for the third quarter ended...

XENT : 28.24 (unch)
First Implants of PROPEL® Contour in Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery in Europe Business Wire - Thu Oct 28, 2021

Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that Helios Dr. Horst Schmidt Kliniken...

XENT : 28.24 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates XENT, INOV, SAFM, HOMB; Shareholders are Encouraged to Contact the Firm Globe NewsWire - Mon Sep 20, 2021

NEW YORK, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

XENT : 28.24 (unch)
INOV : 28.82 (+0.03%)
SAFM : 204.00 (-2.51%)
HOMB : 30.75 (+0.89%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates SBKK, SAFM, LMRK, XENT; Shareholders are Encouraged to Contact the Firm Globe NewsWire - Tue Sep 14, 2021

NEW YORK, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

SBKK : 18.5800 (+1.03%)
SAFM : 204.00 (-2.51%)
LMRK : 16.49 (+0.30%)
XENT : 28.24 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates INOV, LMRK, XENT, JAX; Shareholders are Encouraged to Contact the Firm AccessWire - Mon Sep 13, 2021

NEW YORK, NY / ACCESSWIRE / September 13, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Inovalon Holdings, Inc. (NASDAQ: INOV) concerning...

INOV : 28.82 (+0.03%)
LMRK : 16.49 (+0.30%)
XENT : 28.24 (unch)
JAX : 14.00 (+0.14%)
Lifshitz Law Firm, P.C. Announces Investigation of INOV, XENT, LMRK, and GTS Globe NewsWire - Sat Sep 11, 2021

NEW YORK, Sept. 11, 2021 (GLOBE NEWSWIRE) --

INOV : 28.82 (+0.03%)
XENT : 28.24 (unch)
LMRK : 16.49 (+0.30%)
GTS : 35.99 (+1.04%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates INOV, GTS, XONE, XENT; Shareholders are Encouraged to Contact the Firm AccessWire - Sat Sep 4, 2021

NEW YORK, NY / ACCESSWIRE / September 4, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Inovalon Holdings, Inc. (NASDAQ:INOV) concerning...

INOV : 28.82 (+0.03%)
GTS : 35.99 (+1.04%)
XONE : 49.60 (-0.02%)
XENT : 28.24 (unch)

Barchart Exclusives

Up 99% in the Past Year, How High Can This Growth Stock Rise? Barchart - 1 hour ago
With Lumentum shares skyrocketing over the past year, can this growth stock keep climbing? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot